Global Vaccine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

List of Tables

The global demand for Vaccine Market is presumed to reach the market size of nearly USD 159.11 Billion by 2032 from USD 127.41 Billion in 2023 with a CAGR of 2.5% under the study period 2024-2032.

Vaccines are the substance that protects people from diseases by producing immunity to a specific disease. It contains a dead or weakened version of microbes; these microbes stimulate immune system to produce antibodies. Most vaccines are given by injection, nasally, or by mouth. Depending on strategies utilised to activate or stimulate immune system,vaccines are classified into different types:inactivated, attenuated, toxoid, subunit, experimental, valence, heterotypic and conjugate. There are number of the vaccines under development and yet to commercialise.

MARKET DYNAMICS

Global eradication goals and population expansion are predicted to drive the growth of the vaccine market. Annually, an estimated 2-3 million child deaths and 600,000 adult deaths are prevented by vaccination. Still, there are many diseases that claim millions of lives yearly and for which effective vaccines are not yet available this is giving rise to research and development of the new and improved vaccine. High-income countries are major purchasers of vaccine constituting 82% of global vaccine sales. However, vaccine wastage is identified as a major problem to affect market revenue. There is also another concern that some countries have insufficient funds to buy vaccine while some countries don't have resource or mandate required to conduct the vaccine development due to poor functioning national authorities. This affects the future viability of the vaccine. To assess these factors affecting growth, WHO is taking various measures by developing a set of tools to support programmes and partners to measure and address under-vaccination.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Vaccine. The growth and trends of Vaccine industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Vaccine market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Subunit Vaccines (Recombinant vaccines, Conjugate Vaccines, Toxoid vaccines)
Inactivated
Live Attenuated
mRNA vaccines
Viral vector vaccines

By Route of Administration

Oral
Parenteral
Nasal

By Disease Indication

Viral Diseases (Hepatitis, Influenza, HPV, MMR, Rotavirus, Herpes Zoster, Covid-19, Others)
Bacterial Vaccines (Meningococcal Diseases, Pneumococcal Diseases, DPT, Others)
Cancer Vaccines
Allergy Vaccines

By Age Group

Pediatric
Adult

By Distribution Channel

Hospital & Retail Pharmacies
Government Suppliers
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Vaccine market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Vaccine market include Serum Institute Of India Pvt. Ltd., Seqirus, Sanofi, GSK Plc., Merck & Co. Inc., Pfizer Inc., Moderna Inc., Sinovac, BioNTech SE, AstraZeneca. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11211825

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. VACCINE - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Route of Administration
- 3.7.3 Market Attractiveness Analysis By Disease Indication
- 3.7.4 Market Attractiveness Analysis By Age Group
- 3.7.5 Market Attractiveness Analysis By Distribution Channel
- 3.7.6 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL VACCINE MARKET ANALYSIS BY TYPE

5.1. Overview By Type
5.2. Historical and Forecast Data
5.3. Analysis By Type
5.4. Subunit Vaccines (Recombinant vaccines, Conjugate Vaccines, Toxoid vaccines) Historic and Forecast Sales By Regions
5.5. Inactivated Historic and Forecast Sales By Regions
5.6. Live Attenuated Historic and Forecast Sales By Regions
5.7. mRNA vaccines Historic and Forecast Sales By Regions
5.8. Viral vector vaccines Historic and Forecast Sales By Regions

6. GLOBAL VACCINE MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

6.1. Overview By Route of Administration
6.2. Historical and Forecast Data
6.3. Analysis By Route of Administration
6.4. Oral Historic and Forecast Sales By Regions
6.5. Parenteral Historic and Forecast Sales By Regions
6.6. Nasal Historic and Forecast Sales By Regions

7. GLOBAL VACCINE MARKET ANALYSIS BY DISEASE INDICATION

7.1. Overview By Disease Indication
7.2. Historical and Forecast Data
7.3. Analysis By Disease Indication
7.4. Viral Diseases (Hepatitis, Influenza, HPV, MMR, Rotavirus, Herpes Zoster, Covid-19, Others) Historic and Forecast Sales By Regions
7.5. Bacterial Vaccines (Meningococcal Diseases, Pneumococcal Diseases, DPT, Others) Historic and Forecast Sales By Regions
7.6. Cancer Vaccines Historic and Forecast Sales By Regions
7.7. Allergy Vaccines Historic and Forecast Sales By Regions

8. GLOBAL VACCINE MARKET ANALYSIS BY AGE GROUP

8.1. Overview By Age Group
8.2. Historical and Forecast Data
8.3. Analysis By Age Group
8.4. Pediatric Historic and Forecast Sales By Regions
8.5. Adult Historic and Forecast Sales By Regions

9. GLOBAL VACCINE MARKET ANALYSIS BY DISTRIBUTION CHANNEL

9.1. Overview By Distribution Channel
9.2. Historical and Forecast Data
9.3. Analysis By Distribution Channel
9.4. Hospital & Retail Pharmacies Historic and Forecast Sales By Regions
9.5. Government Suppliers Historic and Forecast Sales By Regions
9.6. Others Historic and Forecast Sales By Regions

10. GLOBAL VACCINE MARKET ANALYSIS BY GEOGRAPHY

10.1. Regional Outlook
10.2. Introduction
10.3. North America Sales Analysis
- 10.3.1 Overview, Historic and Forecast Data Sales Analysis
- 10.3.2 North America By Segment Sales Analysis
- 10.3.3 North America By Country Sales Analysis
- 10.3.4 United States Sales Analysis
- 10.3.5 Canada Sales Analysis
- 10.3.6 Mexico Sales Analysis
10.4. Europe Sales Analysis
- 10.4.1 Overview, Historic and Forecast Data Sales Analysis
- 10.4.2 Europe By Segment Sales Analysis
- 10.4.3 Europe By Country Sales Analysis
- 10.4.4 United Kingdom Sales Analysis
- 10.4.5 France Sales Analysis
- 10.4.6 Germany Sales Analysis
- 10.4.7 Italy Sales Analysis
- 10.4.8 Russia Sales Analysis
- 10.4.9 Rest Of Europe Sales Analysis
10.5. Asia Pacific Sales Analysis
- 10.5.1 Overview, Historic and Forecast Data Sales Analysis
- 10.5.2 Asia Pacific By Segment Sales Analysis
- 10.5.3 Asia Pacific By Country Sales Analysis
- 10.5.4 China Sales Analysis
- 10.5.5 India Sales Analysis
- 10.5.6 Japan Sales Analysis
- 10.5.7 South Korea Sales Analysis
- 10.5.8 Australia Sales Analysis
- 10.5.9 South East Asia Sales Analysis
- 10.5.10 Rest Of Asia Pacific Sales Analysis
10.6. Latin America Sales Analysis
- 10.6.1 Overview, Historic and Forecast Data Sales Analysis
- 10.6.2 Latin America By Segment Sales Analysis
- 10.6.3 Latin America By Country Sales Analysis
- 10.6.4 Brazil Sales Analysis
- 10.6.5 Argentina Sales Analysis
- 10.6.6 Peru Sales Analysis
- 10.6.7 Chile Sales Analysis
- 10.6.8 Rest of Latin America Sales Analysis
10.7. Middle East & Africa Sales Analysis
- 10.7.1 Overview, Historic and Forecast Data Sales Analysis
- 10.7.2 Middle East & Africa By Segment Sales Analysis
- 10.7.3 Middle East & Africa By Country Sales Analysis
- 10.7.4 Saudi Arabia Sales Analysis
- 10.7.5 UAE Sales Analysis
- 10.7.6 Israel Sales Analysis
- 10.7.7 South Africa Sales Analysis
- 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE VACCINE COMPANIES

11.1. Vaccine Market Competition
11.2. Partnership/Collaboration/Agreement
11.3. Merger And Acquisitions
11.4. New Product Launch
11.5. Other Developments

12. COMPANY PROFILES OF VACCINE INDUSTRY

12.1. Top Companies Market Share Analysis
12.2. Market Concentration Rate
12.3. Serum Institute Of India Pvt. Ltd.
- 12.3.1 Company Overview
- 12.3.2 Company Revenue
- 12.3.3 Products
- 12.3.4 Recent Developments
12.4. Seqirus
- 12.4.1 Company Overview
- 12.4.2 Company Revenue
- 12.4.3 Products
- 12.4.4 Recent Developments
12.5. Sanofi
- 12.5.1 Company Overview
- 12.5.2 Company Revenue
- 12.5.3 Products
- 12.5.4 Recent Developments
12.6. GSK Plc.
- 12.6.1 Company Overview
- 12.6.2 Company Revenue
- 12.6.3 Products
- 12.6.4 Recent Developments
12.7. Merck & Co. Inc.
- 12.7.1 Company Overview
- 12.7.2 Company Revenue
- 12.7.3 Products
- 12.7.4 Recent Developments
12.8. Pfizer Inc.
- 12.8.1 Company Overview
- 12.8.2 Company Revenue
- 12.8.3 Products
- 12.8.4 Recent Developments
12.9. Moderna Inc.
- 12.9.1 Company Overview
- 12.9.2 Company Revenue
- 12.9.3 Products
- 12.9.4 Recent Developments
12.10. Sinovac
- 12.10.1 Company Overview
- 12.10.2 Company Revenue
- 12.10.3 Products
- 12.10.4 Recent Developments
12.11. BioNTech SE
- 12.11.1 Company Overview
- 12.11.2 Company Revenue
- 12.11.3 Products
- 12.11.4 Recent Developments
12.12. AstraZeneca
- 12.12.1 Company Overview
- 12.12.2 Company Revenue
- 12.12.3 Products
- 12.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies